Skip to content

PFE

PFIZER INC

NYSE · Healthcare · Drug Manufacturers - General · US

$30.42
+1.38%
Ask drillr

Income statement

MetricTTM2025202420232022
Revenue
Total Revenue63.6B62.6B63.6B59.6B101.2B
Cost of Revenue16.9B16.1B17.9B25.0B34.3B
Gross Profit46.7B46.5B45.8B34.6B66.8B
Operating Expenses
R&D Expense11.5B10.4B10.8B10.7B11.4B
SG&A Expense13.8B13.8B14.7B14.8B13.7B
General & Admin Expense3.3B————
Selling & Marketing Expense—————
Other Expenses6.2B4.9B5.3B4.7B3.6B
Total Operating Expenses31.5B29.1B30.8B30.2B28.7B
Cost and Expenses48.5B45.2B48.7B55.1B63.1B
Operating Income (EBIT)15.2B17.4B14.9B4.4B38.1B
Non-Operating
Interest Income502.0M603.0M545.0M1.6B251.0M
Interest Expense2.7B2.7B3.1B2.2B1.2B
Net Interest Income(2.2B)(2.1B)(2.5B)(585.0M)(987.0M)
Other Non-Op Income/Expense(10.9B)(9.9B)(6.9B)(3.4B)(3.4B)
Non-Operating Income (excl Interest)8.2B7.2B3.8B1.1B2.1B
EBT (Pre-Tax Income)4.3B7.5B8.0B1.1B34.7B
Income Tax Expense186.0M(266.0M)(28.0M)(1.1B)3.3B
Bottom Line
Net Income4.0B7.8B8.0B2.1B31.4B
Earnings from Cont. Ops4.1B7.8B8.1B2.2B31.4B
Earnings from Discont. Ops(5.0M)25.0M11.0M(15.0M)6.0M
Bottom Line Net Income4.0B7.8B8.0B2.1B31.4B
Per Share
Basic EPS$0.71$1.36$1.42$0.38$5.59
Diluted EPS$0.70$1.36$1.41$0.37$5.47
Revenue Per Share$11.16$11.01$11.23$10.55$18.04
Shares
Basic Shares Outstanding5.7B5.7B5.7B5.6B5.6B
Diluted Shares Outstanding5.8B5.7B5.7B5.7B5.7B
Profitability Metrics
EBITDA13.5B16.8B18.1B9.6B41.0B
D&A6.5B6.6B7.0B6.3B5.1B
EBIT7.0B10.2B11.1B3.3B36.0B

As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Sep 1, 2026